241 related articles for article (PubMed ID: 15341515)
41. Inhibition of amyloid beta-peptide production by blockage of beta-secretase cleavage site of amyloid precursor protein.
Na CH; Jeon SH; Zhang G; Olson GL; Chae CB
J Neurochem; 2007 Jun; 101(6):1583-95. PubMed ID: 17542811
[TBL] [Abstract][Full Text] [Related]
42. Length and overall sequence of the PEN-2 C-terminal domain determines its function in the stabilization of presenilin fragments.
Prokop S; Haass C; Steiner H
J Neurochem; 2005 Jul; 94(1):57-62. PubMed ID: 15953349
[TBL] [Abstract][Full Text] [Related]
43. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
[TBL] [Abstract][Full Text] [Related]
44. Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease.
Pollack SJ; Lewis H
Curr Opin Investig Drugs; 2005 Jan; 6(1):35-47. PubMed ID: 15675602
[TBL] [Abstract][Full Text] [Related]
45. Novel alpha-secretase cleavage of Alzheimer's amyloid beta precursor protein in the endoplasmic reticulum of COS7 cells.
Shin RW; Saido TC; Maeda M; Kitamoto T
Neurosci Lett; 2005 Mar; 376(1):14-9. PubMed ID: 15694266
[TBL] [Abstract][Full Text] [Related]
46. Gamma-secretase: a catalyst of Alzheimer disease and signal transduction.
Li YM
Mol Interv; 2001 Oct; 1(4):198-207. PubMed ID: 14993342
[TBL] [Abstract][Full Text] [Related]
47. Reconstitution of gamma-secretase by truncated presenilin (PS) fragments revealed that PS C-terminal transmembrane domain is critical for formation of gamma-secretase complex.
Shiraishi H; Marutani T; Wang HQ; Maeda Y; Kurono Y; Takashima A; Araki W; Nishimura M; Yanagisawa K; Komano H
Genes Cells; 2006 Jan; 11(1):83-93. PubMed ID: 16371134
[TBL] [Abstract][Full Text] [Related]
48. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
[TBL] [Abstract][Full Text] [Related]
49. Presenilin-1 differentially facilitates endoproteolysis of the beta-amyloid precursor protein and Notch.
Capell A; Steiner H; Romig H; Keck S; Baader M; Grim MG; Baumeister R; Haass C
Nat Cell Biol; 2000 Apr; 2(4):205-11. PubMed ID: 10783238
[TBL] [Abstract][Full Text] [Related]
50. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF
J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745
[TBL] [Abstract][Full Text] [Related]
51. Presenilin function and gamma-secretase activity.
Brunkan AL; Goate AM
J Neurochem; 2005 May; 93(4):769-92. PubMed ID: 15857382
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of nicastrin increases Abeta production.
Murphy MP; Das P; Nyborg AC; Rochette MJ; Dodson MW; Loosbrock NM; Souder TM; McLendon C; Merit SL; Piper SC; Jansen KR; Golde TE
FASEB J; 2003 Jun; 17(9):1138-40. PubMed ID: 12692078
[TBL] [Abstract][Full Text] [Related]
53. Structural locations and functional roles of new subsites S5, S6, and S7 in memapsin 2 (beta-secretase).
Turner RT; Hong L; Koelsch G; Ghosh AK; Tang J
Biochemistry; 2005 Jan; 44(1):105-12. PubMed ID: 15628850
[TBL] [Abstract][Full Text] [Related]
54. Presenilin-directed inhibitors of gamma-secretase trigger caspase 3 activation in presenilin-expressing and presenilin-deficient cells.
Alves da Costa C; Ayral E; Hernandez JF; St George-Hyslop P; Checler F
J Neurochem; 2004 Aug; 90(4):800-6. PubMed ID: 15287885
[TBL] [Abstract][Full Text] [Related]
55. Glycine 384 is required for presenilin-1 function and is conserved in bacterial polytopic aspartyl proteases.
Steiner H; Kostka M; Romig H; Basset G; Pesold B; Hardy J; Capell A; Meyn L; Grim ML; Baumeister R; Fechteler K; Haass C
Nat Cell Biol; 2000 Nov; 2(11):848-51. PubMed ID: 11056541
[TBL] [Abstract][Full Text] [Related]
56. Designed helical peptides inhibit an intramembrane protease.
Das C; Berezovska O; Diehl TS; Genet C; Buldyrev I; Tsai JY; Hyman BT; Wolfe MS
J Am Chem Soc; 2003 Oct; 125(39):11794-5. PubMed ID: 14505382
[TBL] [Abstract][Full Text] [Related]
57. An inverse mammalian two-hybrid system for beta secretase and other proteases.
Dixon EP; Johnstone EM; Liu X; Little SP
Anal Biochem; 1997 Jul; 249(2):239-41. PubMed ID: 9212876
[No Abstract] [Full Text] [Related]
58. Presenilin endoproteolysis mediated by an aspartyl protease activity pharmacologically distinct from gamma-secretase.
Campbell WA; Reed ML; Strahle J; Wolfe MS; Xia W
J Neurochem; 2003 Jun; 85(6):1563-74. PubMed ID: 12787075
[TBL] [Abstract][Full Text] [Related]
59. Prediction of the tertiary structure of the beta-secretase zymogen.
Chou KC; Howe WJ
Biochem Biophys Res Commun; 2002 Apr; 292(3):702-8. PubMed ID: 11922623
[TBL] [Abstract][Full Text] [Related]
60. Aspartyl protease inhibitor pepstatin binds to the presenilins of Alzheimer's disease.
Evin G; Sharples RA; Weidemann A; Reinhard FB; Carbone V; Culvenor JG; Holsinger RM; Sernee MF; Beyreuther K; Masters CL
Biochemistry; 2001 Jul; 40(28):8359-68. PubMed ID: 11444983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]